about
A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acidsDNA release dynamics from reducible polyplexes by atomic force microscopy.Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric PlerixaforCross-linked bioreducible layer-by-layer films for increased cell adhesion and transgene expression.DNA release dynamics from bioreducible layer-by-layer films.Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine.Tuning the mechanical properties of bioreducible multilayer films for improved cell adhesion and transfection activityIn situ AFM analysis investigating disassembly of DNA nanoparticles and nano-films.Development of long-circulating polyelectrolyte complexes for systemic delivery of genes.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Bioreducible polycations in nucleic acid delivery: past, present, and future trends.A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseasesBalancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexesReducible poly(2-dimethylaminoethyl methacrylate): synthesis, cytotoxicity, and gene delivery activity.Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.Polymeric drugs: Advances in the development of pharmacologically active polymers.Stimulus-controlled delivery of drugs and genes.Polyplex gene delivery modulated by redox potential gradients.Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors.Dually responsive multiblock copolymers via RAFT polymerization: Synthesis of temperature- and redox-responsive copolymers of PNIPAM and PDMAEMA.Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness.Effect of cell membrane thiols and reduction-triggered disassembly on transfection activity of bioreducible polyplexesGene delivery in vitro and in vivo from bioreducible multilayered polyelectrolyte films of plasmid DNA.Transfection activity of layer-by-layer plasmid DNA/poly(ethylenimine) films deposited on PLGA microparticles.Opposing influence of intracellular and membrane thiols on the toxicity of reducible polycationsSynthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer.Evaluation of pharmacokinetics of bioreducible gene delivery vectors by real-time PCR.Bisethylnorspermine lipopolyamine as potential delivery vector for combination drug/gene anticancer therapies.Chloroquine-Containing HPMA Copolymers as Polymeric Inhibitors of Cancer Cell Migration Mediated by the CXCR4/SDF-1 Chemokine Axis.Bioreducible hyperbranched poly(amido amine)s for gene delivery.DNA release dynamics from bioreducible poly(amido amine) polyplexes.Effect of innate glutathione levels on activity of redox-responsive gene delivery vectorsRecent advances in delivery of drug-nucleic acid combinations for cancer treatmentThe practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.Chloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy.Development of functional poly(amido amine) CXCR4 antagonists with the ability to mobilize leukocytes and deliver nucleic acids.Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer.Polymeric Plerixafor: effect of PEGylation on CXCR4 antagonism, cancer cell invasion, and DNA transfection.Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy.
P50
Q24794521-372E70BE-7EB6-4CD2-8D26-AEE435AB7616Q33671439-ED9024BE-28CC-43C6-A0A4-AF3E3CBE5D7BQ33687703-928EE7F9-86F3-472A-918A-FC8668E00D80Q33817173-BA3FD0E2-455C-4146-8AB7-6EEED0AF4CF5Q33879369-BA9066F4-1A1A-4F74-83FC-4F7F4AB149FFQ33940884-0B667B3F-19C8-4642-9673-C1C00018FCE3Q33997374-43428510-F3E2-43D8-9CDF-05079CB2A286Q34446466-02681F9E-C695-47EF-A303-53C9FBFE9BECQ34696105-BE9EEFB8-CA6B-427C-B88B-8345FF04E7B0Q35167546-178C44EE-008B-4320-B4B0-E12A706190E8Q35539055-27BD6A8F-E9A7-4CF3-945C-9373FDEE8949Q35774071-A01ED64A-77EF-42B8-BCA8-AA5A637096DCQ35801350-93344975-8104-4362-8F79-15D0ACBB0B40Q36116663-CA9FE1F6-1129-481C-B51B-38DA0BAA2693Q36271313-0A74411D-2F6C-4F09-96D0-8737846D3AB1Q36306814-546BC7E5-35B7-495F-92F1-6F32F9F0B807Q36307604-B9A38F8C-9030-442D-8E9B-383611AC67CCQ36316864-CD65A913-B378-478C-9060-C02733958A81Q36627789-0B990DC8-327C-4FE9-B1C6-2F9A6805DE20Q36669884-7DEDA27B-8111-42C4-908B-4CB9DD5BF4C7Q36865931-2F67096F-2795-4901-A953-A220490E55F7Q37045471-EFF7CBBB-7FC9-4E38-8D48-E6EFF7EC2D67Q37062939-BB987C87-03DE-4790-8FEB-5A93A05E71B3Q37078569-8CB9570F-C4B0-49FE-BAB1-3F161E48AF7AQ37093026-451C4FB9-3419-484E-B32B-FE2A06FAB6B1Q37180892-F22F9BB3-035B-4F0D-9FBC-7795BBF6A0B3Q37243049-2899B00E-24D5-4A02-9840-1A54885B4143Q37262502-9BB58E88-A40C-424F-A745-504ABFC863B1Q37267767-0332C1C3-3287-4022-91F9-3236AD0429EDQ37375733-818A2134-DE52-4072-A8B8-9F21B23B6BCAQ37384338-1804678B-26BA-45D1-A2BB-9210F2C0F327Q37388713-410A6FF2-2D26-4F26-B9F7-271CEC90E8EDQ37468294-328211A3-CD54-4269-9E9B-1776CEB5A761Q38102522-33958CAE-79CB-4236-B869-52C5BACCBC97Q38215663-25C26749-5365-4728-B1FC-2073BA53E015Q38657644-BC4F4E00-3A10-41DC-9816-5AC139611AE0Q38930550-3C8114AF-8521-47A6-A419-A70F0130B364Q38963161-F5B2F351-EB60-4CF6-B760-70CE9911C885Q38983304-445FBFAB-3AEB-440D-BE71-A5FEE78AA8E6Q39065397-38C2EAB5-026F-4DE6-A699-33B882EE0539
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Oupický
@ast
David Oupický
@en
David Oupický
@es
David Oupický
@sl
type
label
David Oupický
@ast
David Oupický
@en
David Oupický
@es
David Oupický
@sl
altLabel
David Oupický
@en
prefLabel
David Oupický
@ast
David Oupický
@en
David Oupický
@es
David Oupický
@sl
P1053
C-7220-2009
P106
P1153
6701768056
P21
P31
P496
0000-0003-4710-861X